I’d also like specifics about the “not statistically significant” part - because otherwise there can be a suspicion of cherry-picking the available data. Which I felt, reading parts 2 and 3 of these blog posts, was definitely a possibility.
That said, I don't think it's fair to characterize the COVID study as low-quality. It's worth mentioning contrary results, even if it's an exception that proves the rule.